LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Non-Current Debt (2015 - 2026)

LivaNova's (LIVN) quarterly Non-Current Debt came in at $290.1 million in Q2 2026, down 32.63% year-over-year from $430.6 million in Q2 2025, and up 1.68% quarter-over-quarter from $285.3 million in Q1 2026.

Analysis

LivaNova (LIVN) Non-Current Debt (2015 - 2026) Analysis & Trends

LivaNova has disclosed Non-Current Debt across 12 years of filings, most recently posting $290.1 million for Q2 2026.

  • In Q2 2026, Non-Current Debt fell 32.63% year-over-year to $290.1 million; the TTM figure through Jun 2026 stood at $290.1 million (down 32.63% YoY), while the FY2025 annual figure was $376.1 million, down 40.02% from the prior year.
  • Non-Current Debt came in at $290.1 million for Q2 2026 at LivaNova, up from $285.3 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $628.2 million in Q1 2025 to a low of $285.3 million in Q1 2026.
  • Average Non-Current Debt over 5 years is $513.5 million, with a median of $540.4 million recorded in 2022.
  • Year-over-year, Non-Current Debt surged 129.09% in 2022 and slumped 54.58% in 2026.
  • Over 5 years, Non-Current Debt stood at $539.0 million in 2022, then climbed by 8.72% to $586.0 million in 2023, then grew by 6.99% to $627.0 million in 2024, then slumped by 40.02% to $376.1 million in 2025, then slipped by 22.87% to $290.1 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Debt figures were $290.1 million in Q2 2026, $285.3 million in Q1 2026, and $376.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 29.60 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 25.62 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 14.19 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 10.92 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 598.70 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -1.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 1.65 Bn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn 290.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 290.10 Mn
Mar 31, 2026 285.30 Mn
Dec 31, 2025 376.10 Mn
Sep 30, 2025 434.45 Mn
Jun 30, 2025 430.59 Mn
Mar 31, 2025 628.15 Mn
Dec 31, 2024 627.00 Mn
Sep 30, 2024 625.54 Mn
Jun 30, 2024 624.54 Mn
Mar 31, 2024 623.82 Mn
Dec 31, 2023 586.03 Mn
Sep 30, 2023 586.58 Mn
Jun 30, 2023 586.40 Mn
Mar 31, 2023 541.76 Mn
Dec 31, 2022 539.00 Mn
Sep 30, 2022 537.00 Mn
Jun 30, 2022 463.00 Mn
Mar 31, 2022 457.54 Mn
Dec 31, 2021 236.80 Mn
Sep 30, 2021 234.41 Mn